GABA治疗促进脑膜瘤细胞凋亡并与EGFR/BCL-2/BAX轴相关
本研究通过LC-MS/MS比较正常脑膜与脑膜瘤组织的差异代谢物,分离患者来源的原代脑膜瘤细胞,在体内外评估GABA的抑瘤作用。结果显示GABA抑制脑膜瘤细胞增殖、降低EGFR与BCL-2表达、升高BAX表达,并减小肿瘤体积与重量,提示其促凋亡作用可能与EGFR-BCL-2/BAX通路相关。
要点
- GABA在体外抑制脑膜瘤细胞增殖并促进凋亡。
- GABA下调EGFR与BCL-2、上调BAX表达。
- 体内实验中GABA使肿瘤体积与重量显著减小。
核心结论
- GABA治疗促进脑膜瘤细胞凋亡,可能通过EGFR-BCL-2/BAX信号通路发挥作用。
- 研究提示GABA可能具有用于脑膜瘤治疗的潜在价值。
研究设计与样本
- 采用LC-MS/MS比较正常脑膜与脑膜瘤肿瘤组织的差异表达代谢物。
- 从患者来源的脑膜瘤肿瘤组织分离原代脑膜瘤细胞。
- 在体内和体外评估GABA的促肿瘤作用。
主要发现
- 定量检测到37种氨基酸,其中GABA差异较为明显。
- 克隆形成实验和流式细胞术分析显示GABA处理抑制脑膜瘤细胞增殖。
- Western blot和EGFR荧光实验显示GABA抑制EGFR表达,实验组较对照组BCL-2表达明显降低、BAX表达显著升高。
- 免疫组化结果显示实验组EGFR表达显著降低。
- GABA处理后肿瘤体积和肿瘤重量显著减小。
临床怎么用
- 本研究为GABA作为脑膜瘤潜在系统治疗方向提供了临床前实验依据。
- EGFR-BCL-2/BAX轴可作为后续脑膜瘤治疗研究的候选信号通路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Meningioma is one of the most common primary tumors in the central nervous system (CNS). However, potential systemic therapies for the treatment of meningioma are limited. This study aimed to identify novel therapeutic targets for the treatment of meningioma. METHODS: In this study, we characterized the differentially expressed metabolites between normal meninges and meningioma tumor tissues with liquid chromatography‒mass spectrometry (LC‒MS/MS). Primary meningioma cells were isolated from patient-derived meningioma tumor tissues. The tumor-promoting roles of γ-aminobutyric acid (GABA) were assessed in vivo and in vitro. RESULTS: In this study, 37 amino acids were quantitatively detected, with GABA exhibiting more pronounced differences. Colony formation assay and flow cytometry analyses revealed that treatment with GABA inhibited the proliferation of meningioma cells. Western blot and EGFR fluorescence experiments revealed that GABA inhibited EGFR expression with a notable decrease in BCL-2 expression and a significant increase in BAX expression in the experimental group compared with the control group. The immunohistochemical results showed a significant decrease in the expression of EGFR in the experimental group. And The tumor volume and tumor weight were significantly decreased following treatment with GABA. CONCLUSIONS: GABA treatment promoted meningioma cell apoptosis which might correlate with the EGFR-BCL-2/BAX signaling pathway. Our study suggested that GABA could be therapeutically useful for managing meningioma.
引用
- Yang X, Wang L, Wu H, et al. GABA treatment promoting cell apoptosis in meningioma correlates with EGFR/BCL-2/BAX axis. J Neurooncol. 2025. PMID: 41217545. doi:10.1007/s11060-025-05334-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。